Skip to main content
Premium Trial:

Request an Annual Quote

Alex Zrolka, Stan Letovsky, Kevin Sayer

Premium
Invetech has named Alex Zrolka vice president of business development for the company’s North American life sciences division, the firm said last week.
 
Zrolka previously worked in marketing management, business development, and sales for Biotech Envoy, Genicon Sciences, Qiagen, Bio-Rad Laboratories, and DNAStar.
 

 
Codon Devices has named Stan Letovsky executive director of bioinformatics and information technology, the company said last week.
 
Letovsky most recently was senior director of computational sciences at Millennium Pharmaceuticals.
 
He also was in global bioinformatics with Monsanto and worked on the Genome Database Project at Johns Hopkins Medical Institute.   
 

 
Kevin Sayer will join the board of directors at Eksigent, the company said last week.
 
Sayer, a biotech and pharmaceutical industry consultant, was named to the board as part of the company’s expansion of its medical devices segment, Eksigent said.

Filed under

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.